AMANDA MILLER: Open Payments
NPI 1851005854 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,768 in 127 payments from 17 companies in 2025. Trend: 2023 $2,370 · 2024 $1,166 · 2025 $2,768
Food & beverage: $2,768
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 28 | $707 |
| AstraZeneca Pharmaceuticals LP | 13 | $533 |
| Novartis Pharmaceuticals Corporation | 19 | $320 |
| CSL Behring | 15 | $278 |
| Regeneron Healthcare Solutions, Inc. | 8 | $205 |
| GlaxoSmithKline, LLC. | 17 | $192 |
| BioCryst US Sales Co., LLC | 10 | $183 |
| Grifols USA, LLC | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| Ionis Pharmaceuticals, Inc. | 2 | $48 |
Products named: DUPIXENT, TEZSPIRE, ORLADEYO, FASENRA, TRELEGY ELLIPTA, AIRSUPRA, Rhapsido, Hizentra.
Industry payments across KY — which companies pay providers there.
